Glia-specific antigen in the intracranial tumors. Immunofluorescence study
- PMID: 345726
- DOI: 10.1007/BF00689550
Glia-specific antigen in the intracranial tumors. Immunofluorescence study
Abstract
26 gliomas and 14 non-glial tumors were examined for the presence of nervous system specific antigen (CGSA) to assess the antigenic properties of neoplastic tissue in relation to histogenesis and degree of differentiation of tumors. Double layer immunofluorescence (IMF) technique was used for the cellular localization of the antigen. CGSA was found in the cytoplasm of normal, reactive and neoplastic neuroglial cells. Well differentiated astrocytomas showed the strongest IMF reactions and largest number of IMF-positive cells. Tumors with histological signs of anaplasia displayed foci of IMF-negative cells irregularly distributed in the sections. There were no completely negative astrocytomas owing to a marked affinity of the specific astisera to the astrocytic cell line. In the oligodendrogliomas a smaller amount of the antigen was found than in the astrocytomas. Histological evidence of malignancy in these tumors was accompanied by strikingly small number of positive cells and weaker IMF reactions as compared to the well differentiated oligodendrogliomas. Anaplastic gliomas showed only traces of CGSA and non-glial tumors were entirely negative. The results suggest a deficiency of normal antigenic material in the neoplastic glia, particularly of oligodendrogliomas and anaplastic gliomas.
Similar articles
-
Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.Eur Neurol. 1983;22(5):307-13. doi: 10.1159/000115577. Eur Neurol. 1983. PMID: 6628459
-
[Immunochemical and immunological study of human brain tumors].Int J Cancer. 1972 Mar 15;9(2):374-82. doi: 10.1002/ijc.2910090216. Int J Cancer. 1972. PMID: 4339413 French. No abstract available.
-
Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.Zhonghua Yi Xue Za Zhi (Taipei). 1994 Apr;53(4):193-7. Zhonghua Yi Xue Za Zhi (Taipei). 1994. PMID: 7911730
-
Pathologic analysis of primary brain tumors.Neurol Clin. 1985 Nov;3(4):711-28. Neurol Clin. 1985. PMID: 3001488 Review.
-
Viruses and brain tumors.Clin Neurosurg. 1974;21:362-82. doi: 10.1093/neurosurgery/21.cn_suppl_1.362. Clin Neurosurg. 1974. PMID: 4371589 Review. No abstract available.
Cited by
-
Identification of mitophagy-related genes impacting patient survival in glioma.Discov Oncol. 2025 Feb 9;16(1):140. doi: 10.1007/s12672-025-01916-6. Discov Oncol. 2025. PMID: 39923213 Free PMC article.
-
Computerized classification of gliomas by automated microscope picture analysis (AMPA).Acta Neuropathol. 1982;58(4):261-8. doi: 10.1007/BF00688607. Acta Neuropathol. 1982. PMID: 6297226 No abstract available.
-
Glial fibrillary acidic protein in giant cell tumors of brain and other gliomas. A possible relationship to malignancy, differentiation, and pleomorphism of glia.Acta Neuropathol. 1980;52(1):51-7. doi: 10.1007/BF00687228. Acta Neuropathol. 1980. PMID: 7435156 No abstract available.
-
The biology of human brain tumours.Acta Neurochir (Wien). 1979;50(1-2):7-34. doi: 10.1007/BF01813545. Acta Neurochir (Wien). 1979. PMID: 517186 No abstract available.
-
The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.Acta Neurochir (Wien). 1981;55(3-4):181-200. doi: 10.1007/BF01808436. Acta Neurochir (Wien). 1981. PMID: 7015801